January 2010
Selected Research in Men’s Health
Bone
Abrahamsen B, Brixen K. Mapping the prescriptiome to fractures in men--a national analysis of prescription history and fracture risk. Osteoporosis Int. 2009;20:585-597.PubMed Abstract
Benetos A, Zervoudaki A, Kearney-Schwartz A, et al. Effects of lean and fat mass on bone mineral density and arterial stiffness in elderly men. Osteoporosis Int. 2009;20:1385-1391. PubMed Abstract
Burnett-Bowie SA, McKay EA, Lee H, Leder BZ. Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels. Journal of Clinical Endocrinology & Metabolism. 2009;94:4785-4792. PubMed Abstract
Cawthon PM. Ewing SK. McCulloch CE. Ensrud KE. Cauley JA. Cummings SR. Orwoll ES. Osteoporotic Fractures in Men (MrOS) Research Group. Loss of hip BMD in older men: The osteoporotic fractures in men (MrOS) study. Journal of Bone & Mineral Research. 2009;24:1728-1735. PubMed Abstract
Lapauw B, Taes Y, Goemaere S, Toye K, Zmierczak HG, Kaufman JM. Anthropometric and skeletal phenotype in men with idiopathic osteoporosis and their sons is consistent with deficient estrogen action during maturation. Journal of Clinical Endocrinology & Metabolism. 2009;94:4300-4308. PubMed Abstract
Papaioannou A, Kennedy CC, Cranney A, et al. Risk factors for low BMD in healthy men age 50 years or older: A systematic review. Osteoporosis Int. 2009;20:507-518. PubMed Abstract
Richards JS, Peng J, Amdur RL, et al. Dual-energy X-ray absorptiometry and evaluation of the osteoporosis self-assessment tool in men with rheumatoid arthritis. Journal of Clinical Densitometry. 2009;12:434-440. PubMed Abstract
Cardiovascular
Arnlov J, Ingelsson E, Sundstrom J, Lind L. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation. 2010;121:230-236. PubMed Abstract
Cordero A. Andrés E. Ordoñez B. León M. Laclaustra M. Grima A. Luengo E. Moreno J. Bes M. Pascual I. Civeira F. Pocoví M. Alegría E. Casasnovas JA. MEtabolic Syndrome Active Subjects Study Investigators. Usefulness of triglycerides-to-high-density lipoprotein cholesterol ratio for predicting the first coronary event in men. Am J Cardiol. 2009;104:1393-1397. PubMed Abstract
Hall SA, Shackelton R, Rosen RC, Araujo AB. Sexual activity, erectile dysfunction, and incident cardiovascular events. Am J Cardiol. 2010;105:192-197. PubMed Abstract
Hu X, Jiang H, Xu C, Zhou X, Cui B, Lu Z. Relationship between sex hormones and idiopathic outflow tract ventricular arrhythmias in adult male patients. Translational Research: The Journal Of Laboratory & Clinical Medicine. 2009;154:265-268. PubMed Abstract
Kawada T, Otsuka T, Inagaki H, Wakayama Y, Li Q, Katsumata M. Relationship between two indicators of coronary risk estimated by the framingham risk score and the number of metabolic syndrome components in japanese male manufacturing workers. Metabolic Syndrome & Related Disorders. 2009;7:435-440. PubMed Abstract
Levitan EB, Wolk A, Mittleman MA. Relation of consistency with the dietary approaches to stop hypertension diet and incidence of heart failure in men aged 45 to 79 years. Am J Cardiol. 2009;104:1416-1420. PubMed Abstract
McAuley P, Myers J, Emerson B, et al. Cardiorespiratory fitness and mortality in diabetic men with and without cardiovascular disease. Diabetes Research & Clinical Practice. 2009;85:e30-3. PubMed Abstract
Mulat B, Arbel Y, Mashav N, et al. Depressive symptoms and erectile dysfunction in men with coronary artery disease. Urology. 2009. PubMed Abstract
Salem MK, Rayt HS, Hussey G, et al. Should asian men be included in abdominal aortic aneurysm screening programmes?. European Journal of Vascular & Endovascular Surgery. 2009;38:748-749. PubMed Abstract
Virtanen JK, Mursu J, Voutilainen S, Tuomainen TP. Serum long-chain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men. Circulation. 2009;120:2315-2321. PubMed Abstract
Prostate
Bergman J, Gore JL, Saigal CS, Kwan L, Litwin MS. Partnership and outcomes in men with prostate cancer. Cancer. 2009;115:4688-4694. PubMed Abstract
Chao C, Haque R, Van Den Eeden SK, Caan BJ, Poon KY, Quinn VP. Red wine consumption and risk of prostate cancer: The california men's health study. International Journal of Cancer. 2010;126:171-179. PubMed Abstract
Ellem SJ, Wang H, Poutanen M, Risbridger GP. Increased endogenous estrogen synthesis leads to the sequential induction of prostatic inflammation (prostatitis) and prostatic pre-malignancy. Am J Pathol. 2009;175:1187-1199. PubMed Abstract
Eyre SJ, Ankerst DP, Wei JT, et al. Validation in a multiple urology practice cohort of the prostate cancer prevention trial calculator for predicting prostate cancer detection. J Urol. 2009;182:2653-2658. PubMed Abstract
Imamoto T, Suzuki H, Utsumi T, et al. Association between serum sex hormone levels and prostate cancer: Effect of prostate cancer on serum testosterone levels. Future Oncology. 2009;5:1005-1013. PubMed Abstract
Lin GA, Aaronson DS, Knight SJ, Carroll PR, Dudley RA. Patient decision aids for prostate cancer treatment: A systematic review of the literature. CA: a Cancer Journal for Clinicians. 2009;59:379-390. PubMed Abstract
Loeb S, Carter HB, Schaeffer EM, Ferrucci L, Kettermann A, Metter EJ. Should prostate specific antigen be adjusted for body mass index? data from the baltimore longitudinal study of aging. J Urol. 2009;182:2646-2651. PubMed Abstract
Moore SC, Peters TM, Ahn J, et al. Age-specific physical activity and prostate cancer risk among white men and black men. Cancer. 2009;115:5060-5070. PubMed Abstract
Oliffe JL, Ogrodniczuk J, Bottorff JL, Hislop TG, Halpin M. Connecting humor, health, and masculinities at prostate cancer support groups. Psychooncology. 2009;18:916-926. PubMed Abstract
Printz C. Many unknowns in low-risk prostate cancer treatment. ongoing studies and biomarker research may shed light on best approach. Cancer. 2009;115:4645-4646. No available abstract.
Wheat JC, Hedgepeth RC, He C, Zhang L, Wood DP,Jr. Clinical interpretation of the expanded prostate cancer index composite-short form sexual summary score. J Urol. 2009;182:2844-2849. PubMed Abstract
Testosterone
Corona G, Mannucci E, Forti G, Maggi M. Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes? Int J Androl. 2009;32:431-441. PubMed Abstract
Di Luigi L. Sgrò P. Romanelli F. Mazzarino M. Donati F. Braganò MC. Bianchini S. Fierro V. Casasco M. Botrè F. Lenzi A. Urinary and serum hormones profiles after testosterone enanthate administration in male hypogonadism: Concerns on the detection of doping with testosterone in treated hypogonadal athletes. J Endocrinol Invest. 2009;32:445-453. PubMed Abstract
Fintini D, Grossi A, Brufani C, et al. Bone mineral density and body composition in male children with hypogonadism. J Endocrinol Invest. 2009;32:585-589. PubMed Abstract
Kalinchenko S, Zemlyanoy A, Gooren LJ. Improvement of the diabetic foot upon testosterone administration to hypogonadal men with peripheral arterial disease. report of three cases. Cardiovascular Diabetology. 2009;8:19. PubMed Abstract
Kuepper Y, Alexander N, Osinsky R, et al. Aggression--interactions of serotonin and testosterone in healthy men and women. Behav Brain Res. 2010;206:93-100. PubMed Abstract
Kuzawa CW, Gettler LT, Muller MN, McDade TW, Feranil AB. Fatherhood, pairbonding and testosterone in the philippines. Hormones & Behavior. 2009;56:429-435. PubMed Abstract
Romerius P, Stahl O, Moell C, et al. Hypogonadism risk in men treated for childhood cancer. Journal of Clinical Endocrinology & Metabolism. 2009;94:4180-4186. PubMed Abstract
Sapienza P, Zingales L, Maestripieri D. Gender differences in financial risk aversion and career choices are affected by testosterone. Proc Natl Acad Sci U S A. 2009;106:15268-15273. PubMed Abstract
Tsujimura A, Takada S, Matsuoka Y, et al. Adiponectin and testosterone in patients with symptoms of late-onset hypogonadism: Is there a link?. International Journal of Urology. 2009;16:830-835. PubMed Abstract
Sexual
Fujita K, Landis P, McNeil BK, Pavlovich CP. Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance. J Urol. 2009;182:2664-2669. PubMed Abstract
Qaseem A, Snow V, Denberg TD, et al. Hormonal testing and pharmacologic treatment of erectile dysfunction: A clinical practice guideline from the american college of physicians. Ann Intern Med. 2009;151:639-649. PubMed Abstract
Tsertsvadze A, Fink HA, Yazdi F, et al. Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: A systematic review and meta-analysis. Ann Intern Med. 2009;151:650-661. PubMed Abstract
Lifestyle
Heufelder AE, Saad F, Bunck MC, Gooren L. Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone. J Androl. 2009;30:726-733. PubMed Abstract
Lam JC, Yan CS, Lai AY, et al. Determinants of daytime blood pressure in relation to obstructive sleep apnea in men. Lung. 2009;187:291-298. PubMed Abstract
Lee CD, Sui X, Blair SN. Combined effects of cardiorespiratory fitness, not smoking, and normal waist girth on morbidity and mortality in men. Arch Intern Med. 2009;169:2096-2101. PubMed Abstract
McAuley PA, Sui X, Church TS, Hardin JW, Myers JN, Blair SN. The joint effects of cardiorespiratory fitness and adiposity on mortality risk in men with hypertension. American Journal of Hypertension. 2009;22:1062-1069. PubMed Abstract
Shikany JM, Phadke RP, Redden DT, Gower BA. Effects of low- and high-glycemic index/glycemic load diets on coronary heart disease risk factors in overweight/obese men. Metabolism: Clinical & Experimental. 2009;58:1793-1801. PubMed Abstract
